Research programme: diabetic ulcer therapy - SWITCH Biotech
Alternative Names: Diabetic ulcer therapy research programme - SWITCH Biotech; Research programme: wound healing therapy - SWITCH Biotech; SWT 02.100; Wound healing therapy research programme - SWITCH BiotechLatest Information Update: 02 Jun 2005
Price :
$50 *
At a glance
- Originator SWITCH Biotech (CEASED)
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic foot ulcer; Skin ulcer
Most Recent Events
- 01 Mar 2005 Discontinued - Preclinical for Diabetic foot ulcer in Germany (Topical)
- 01 Mar 2005 Discontinued - Preclinical for Skin ulcer in Germany (Topical)
- 01 Mar 2005 SWITCH Biotech has closed down